Bestaande gebruiker? Log in
Abonneren
Home
Beurs vandaag
Koersen
Nieuws
Agenda
Analisten
Analisten vandaag
Meest aanbevolen aandelen
Minst aanbevolen aandelen
Aandelen met grootste potentieel
Insider trading
Insiders vandaag
Meest gekochte aandelen
Meest verkochte aandelen
Mijn Trivano
Mijn Trivano
Mijn selecties
Mijn nieuwsbrieven
Abonneren
Beurs vandaag
Koersen
Nieuws
Agenda
Analisten
Insider trading
Mijn Trivano
Registreren / inloggen
Beurs vandaag
Bausch Health Companies Inc
Nieuws
Bausch Health Companies Inc
BHC
NYS
: BHC
| ISIN: CA0717341071
12/02/2025
6,360 USD
(-0,16%)
(-0,16%)
12/02/2025
Aandeel volgen
Aandeel gevolgd
Samenvatting
Nieuws
Insiders
Dividend
Technische analyse
TA
Toon enkel gratis nieuws
5 oktober 2023 ·
Thinking about trading options or stock in Tesla, Palantir Technologies, Bausch Health Companies, Alphabet Inc, or Shell?
· Persbericht
26 september 2023 ·
SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Bausch Health Companies Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of September 25, 2023 - (NYSE: BHC)
· Persbericht
10 september 2023 ·
Bausch Health Companies Inc. (BHC) Shareholder Reminder: Kessler Topaz Meltzer & Check, LLP Reminds BHC Investors of Securities Fraud Class Action Lawsuit Filed On Their Behalf
· Persbericht
8 september 2023 ·
BHC Investors Have Opportunity to Lead Bausch Health Companies Inc. Securities Fraud Lawsuit
· Persbericht
2 september 2023 ·
Kessler Topaz Meltzer & Check, LLP Reminds BHC Investors of September 25, 2023 Deadline in Securities Fraud Class Action against of Bausch Health Companies Inc. and Urges Investors with Substantial Losses to Contact the Firm
· Persbericht
25 augustus 2023 ·
BHC Investors Have Opportunity to Lead Bausch Health Companies Inc. Securities Fraud Lawsuit
· Persbericht
24 augustus 2023 ·
Kessler Topaz Meltzer & Check, LLP Reminds Bausch Health Companies Inc. Investors of Important Deadline in Securities Fraud Class Action Lawsuit and Encourages Investors with Substantial Losses to Contact the Firm
· Persbericht
14 augustus 2023 ·
Bausch Health Companies Inc. Investors Reminder: Kessler Topaz Meltzer & Check, LLP Reminds Bausch Health Companies Inc. Shareholders of Deadline in Securities Fraud Class Action Lawsuit
· Persbericht
12 augustus 2023 ·
BHC INVESTOR NOTICE: Bausch Health Companies Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
· Persbericht
6 augustus 2023 ·
BHC CLASS ACTION ANNOUNCEMENT: Kessler Topaz Meltzer & Check, LLP Announces Securities Class Action Lawsuit Filed Against Bausch Health Companies Inc. (BHC)
· Persbericht
31 mei 2023 ·
OraPharma and Alex Rodriguez Team Up to Raise Awareness About the Importance of Managing Gum Disease
· Persbericht
12 oktober 2022 ·
Salix Pharmaceuticals Releases Liver Health Annual Trends Report Underscoring Challenges In Caring For Growing Chronic Liver Disease And Cirrhotic Patient Population
· Persbericht
5 oktober 2022 ·
Seasonal Affective Disorder (SAD) Is Now a Recognized Diagnosis in the CMS Tabular Index, Accessible to Prescribers Oct. 1, 2022
· Persbericht
3 oktober 2022 ·
Salix Pharmaceuticals Applauds Implementation Of K76.82 - A New Icd-10 Code For Hepatic Encephalopathy
· Persbericht
28 september 2022 ·
Bausch Health Announces Final Results and Expiration of Exchange Offers and Consent Solicitations
· Persbericht
14 september 2022 ·
Bausch Health Announces Early Exchange Offer Results for Exchange Offers and Consent Solicitations
· Persbericht
9 september 2022 ·
Bausch Health Responds to Norwich Pharmaceuticals Tentative FDA Approval for a 200 mg Rifaximin
· Persbericht
8 september 2022 ·
Bausch Health Clarifies Release Provisions Related to its Exchange Offers and Consent Solicitations
· Persbericht
31 augustus 2022 ·
Bausch Health Announces Exchange Offers and Consent Solicitations for Certain Existing Senior Notes with Support from Approximately 23% of Outstanding Existing Senior Notes
· Persbericht
22 augustus 2022 ·
Bausch Health Continuing Process Toward Separating Bausch + Lomb
· Persbericht
Aandeel volgen
Aandeel gevolgd
Mijn selecties
Voorbeeldselectie
Je selectie is nog leeg.
Voeg nu effecten toe